Rankings
▼
Calendar
XOMAP Q2 2021 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$901,000
+102.9% YoY
Gross Profit
$863,000
95.8% margin
Operating Income
-$3M
-340.1% margin
Net Income
-$2M
-248.3% margin
EPS (Diluted)
$-0.20
QoQ Revenue Growth
+140.3%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$768,000
Balance Sheet
Total Assets
$136M
Total Liabilities
$19M
Stockholders' Equity
$117M
Cash & Equivalents
$79M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$901,000
$444,000
+102.9%
Gross Profit
$863,000
$406,000
+112.6%
Operating Income
-$3M
-$3M
+2.8%
Net Income
-$2M
-$4M
+36.7%
← FY 2021
All Quarters
Q3 2021 →